SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES
The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase. La invención proporciona composic...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KHOSSRAVI Mehrnaz HART Scott Aaron HABY Thomas Arthur MURTHY Bindu Purnima SANGHAVI Kinjal ZHAO Xiaochen BELLO Akintunde VEZINA Heather Elizabeth HUANG Masano ARAS Urvi Ashish ROY Amit MANTRI Rao Venkatramana |
description | The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase.
La invención proporciona composiciones farmacéuticas que comprenden un anticuerpo anti-PD-1 o un anticuerpo anti-PD-L1 formuladas para administración subcutánea, en donde las composiciones farmacéuticas además comprenden una enzima endoglicosidasa hidrolasa, tal como una hialuronidasa. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023007650A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023007650A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023007650A3</originalsourceid><addsrcrecordid>eNrjZDAODnVyDg1x9HP1Dw1WcHTx9fTzDA4Jcgzx9PdT8HdTCHAx1A9w0fUxVHD0C_F08nfxdA3mYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBkbGBgbmZqYGjsZEKQIA8Wcnhg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES</title><source>esp@cenet</source><creator>KHOSSRAVI Mehrnaz ; HART Scott Aaron ; HABY Thomas Arthur ; MURTHY Bindu Purnima ; SANGHAVI Kinjal ; ZHAO Xiaochen ; BELLO Akintunde ; VEZINA Heather Elizabeth ; HUANG Masano ; ARAS Urvi Ashish ; ROY Amit ; MANTRI Rao Venkatramana</creator><creatorcontrib>KHOSSRAVI Mehrnaz ; HART Scott Aaron ; HABY Thomas Arthur ; MURTHY Bindu Purnima ; SANGHAVI Kinjal ; ZHAO Xiaochen ; BELLO Akintunde ; VEZINA Heather Elizabeth ; HUANG Masano ; ARAS Urvi Ashish ; ROY Amit ; MANTRI Rao Venkatramana</creatorcontrib><description>The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase.
La invención proporciona composiciones farmacéuticas que comprenden un anticuerpo anti-PD-1 o un anticuerpo anti-PD-L1 formuladas para administración subcutánea, en donde las composiciones farmacéuticas además comprenden una enzima endoglicosidasa hidrolasa, tal como una hialuronidasa.</description><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230911&DB=EPODOC&CC=MX&NR=2023007650A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230911&DB=EPODOC&CC=MX&NR=2023007650A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KHOSSRAVI Mehrnaz</creatorcontrib><creatorcontrib>HART Scott Aaron</creatorcontrib><creatorcontrib>HABY Thomas Arthur</creatorcontrib><creatorcontrib>MURTHY Bindu Purnima</creatorcontrib><creatorcontrib>SANGHAVI Kinjal</creatorcontrib><creatorcontrib>ZHAO Xiaochen</creatorcontrib><creatorcontrib>BELLO Akintunde</creatorcontrib><creatorcontrib>VEZINA Heather Elizabeth</creatorcontrib><creatorcontrib>HUANG Masano</creatorcontrib><creatorcontrib>ARAS Urvi Ashish</creatorcontrib><creatorcontrib>ROY Amit</creatorcontrib><creatorcontrib>MANTRI Rao Venkatramana</creatorcontrib><title>SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES</title><description>The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase.
La invención proporciona composiciones farmacéuticas que comprenden un anticuerpo anti-PD-1 o un anticuerpo anti-PD-L1 formuladas para administración subcutánea, en donde las composiciones farmacéuticas además comprenden una enzima endoglicosidasa hidrolasa, tal como una hialuronidasa.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAODnVyDg1x9HP1Dw1WcHTx9fTzDA4Jcgzx9PdT8HdTCHAx1A9w0fUxVHD0C_F08nfxdA3mYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBkbGBgbmZqYGjsZEKQIA8Wcnhg</recordid><startdate>20230911</startdate><enddate>20230911</enddate><creator>KHOSSRAVI Mehrnaz</creator><creator>HART Scott Aaron</creator><creator>HABY Thomas Arthur</creator><creator>MURTHY Bindu Purnima</creator><creator>SANGHAVI Kinjal</creator><creator>ZHAO Xiaochen</creator><creator>BELLO Akintunde</creator><creator>VEZINA Heather Elizabeth</creator><creator>HUANG Masano</creator><creator>ARAS Urvi Ashish</creator><creator>ROY Amit</creator><creator>MANTRI Rao Venkatramana</creator><scope>EVB</scope></search><sort><creationdate>20230911</creationdate><title>SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES</title><author>KHOSSRAVI Mehrnaz ; HART Scott Aaron ; HABY Thomas Arthur ; MURTHY Bindu Purnima ; SANGHAVI Kinjal ; ZHAO Xiaochen ; BELLO Akintunde ; VEZINA Heather Elizabeth ; HUANG Masano ; ARAS Urvi Ashish ; ROY Amit ; MANTRI Rao Venkatramana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023007650A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>KHOSSRAVI Mehrnaz</creatorcontrib><creatorcontrib>HART Scott Aaron</creatorcontrib><creatorcontrib>HABY Thomas Arthur</creatorcontrib><creatorcontrib>MURTHY Bindu Purnima</creatorcontrib><creatorcontrib>SANGHAVI Kinjal</creatorcontrib><creatorcontrib>ZHAO Xiaochen</creatorcontrib><creatorcontrib>BELLO Akintunde</creatorcontrib><creatorcontrib>VEZINA Heather Elizabeth</creatorcontrib><creatorcontrib>HUANG Masano</creatorcontrib><creatorcontrib>ARAS Urvi Ashish</creatorcontrib><creatorcontrib>ROY Amit</creatorcontrib><creatorcontrib>MANTRI Rao Venkatramana</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KHOSSRAVI Mehrnaz</au><au>HART Scott Aaron</au><au>HABY Thomas Arthur</au><au>MURTHY Bindu Purnima</au><au>SANGHAVI Kinjal</au><au>ZHAO Xiaochen</au><au>BELLO Akintunde</au><au>VEZINA Heather Elizabeth</au><au>HUANG Masano</au><au>ARAS Urvi Ashish</au><au>ROY Amit</au><au>MANTRI Rao Venkatramana</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES</title><date>2023-09-11</date><risdate>2023</risdate><abstract>The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase.
La invención proporciona composiciones farmacéuticas que comprenden un anticuerpo anti-PD-1 o un anticuerpo anti-PD-L1 formuladas para administración subcutánea, en donde las composiciones farmacéuticas además comprenden una enzima endoglicosidasa hidrolasa, tal como una hialuronidasa.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2023007650A |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | SUBCUTANEOUS ADMINISTRATION OF PD1/PD-L1 ANTIBODIES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A27%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KHOSSRAVI%20Mehrnaz&rft.date=2023-09-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023007650A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |